LUNG: Pulmonx Corp Company Profile & Statistics

About

Pulmonx Corporation is a medical technology company. It designs, develops, manufactures and markets minimally invasive medical devices for the diagnosis and treatment of chronic obstructive pulmonary diseases. Pulmonx Corporation is based in Redwood City, California.

Info & Links

CEO

Glendon E. French

Headquarters

700 CHESAPEAKE DRIVE
REDWOOD CITY, CA 94063, UNITED STATES

Auditor

BDO USA, P.C.

Share holders

136

Employees

279

Pulmonx Corp Statistics

Valuation Measures

Market Capitalization²

237.33M

Enterprise Value

211.00M

Enterprise Value/EBITDA(ttm)

-3.62

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

3.04

Price to Book(mrq)

2.56

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

74.18%

Operating Margin(ttm)

-72.01%

Profit Margin(ttm)

-72.02%

Return on Equity(ttm)

-53.88%

Return on Invested Capital(ttm)

-40.58%

Return on Assets(ttm)

-33.47%

Income Statement

Revenue(ttm)

79.30M

Revenue Per Share(ttm)

2.01

Gross Profit(ttm)

58.81M

EBITDA(ttm)³

-58.27M

Net Income Available to Common(ttm)

-57.11M

Diluted EPS(ttm)

-1.47

Share Statistics

Beta (5Y Monthly)

0.69

52-Week Change

-46.86%

S&P 500 52-Week Change

25.96%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

39.49M

Dividend Yield

0.00%

Float⁴

37.24M

% Held by Insiders

5.70%

% Held by Institutions

91.04%

Balance Sheet

Total Cash(mrq)

108.04M

Total Cash Per Share(mrq)

2.74

Total Debt(mrq)

37.24M

Total Debt/Equity(mrq)

39.64%

Current Ratio(mrq)

7.70%

Quick Ratio(mrq)

6.77%

Book Value Per Share(mrq)

2.38

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.63

Free Cash Flow(ytd)

-26.14M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

LUNG

Pulmonx Corp

Pulmonx Corp Profile